Medtronic has recalled more than 204,000 devices used to assist hospital and other patients with end-stage heart failure due to the potential for power source interruptions, the Food and Drug Administration reported Friday. The HeartWare Ventricular Assist Device is used as a bridge to cardiac transplantation in patients who are at risk of death from end-stage left ventricular heart failure. Health care professionals and consumers may report adverse reactions and quality problems with the devices to the FDA’s MedWatch program. For more information, see the recent Medtronic letter to health care providers.

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Inspector General says it will seek to ensure health care providers retain regulatory flexibility…
Headline
The Department of Health and Human Services' Office for Civil Rights April 3 warned HIPAA-covered entities of an individual posing as an OCR investigator…
Headline
The federal government will use a portion of the Coronavirus Aid, Relief, and Economic Security Act’s $100 billion emergency fund for hospitals and health care…
Headline
The AHA today urged CMS to use its authority to extend to LTCHs the 20% hospital add-on payment for Medicare beneficiaries diagnosed with COVID-19, which was…
Headline
The AHA urged HHS and CMS to consider taking additional actions that would expand the ability of hospitals and health systems to use telehealth in response to…
Headline
The AHA urged the HHS Secretary to consider additional actions to temporarily suspend certain requirements so that health care providers can better respond to…